Frontline therapy and the role of high-dose consolidation in mantle cell lymphoma
Exciting current CLL trials taking place in the UK
What’s next for inotuzumab ozogamicin in ALL?
Exciting new treatments in myeloma
Perspectives in AML treatment: targeting apoptosis without chemotherapy by using BH3-mimetics